What is the address of Société médicale Loze-Thilmany?

The registered office of Société médicale Loze-Thilmany is located at Rue de Labas 24, 5340 Gesves.

Is Société médicale Loze-Thilmany still active?

Yes. According to the CBE (31 October 2026) Société médicale Loze-Thilmany is active, legal situation “Normale toestand”, started on 9 March 2022.

Is Société médicale Loze-Thilmany registered on Peppol?

No, Société médicale Loze-Thilmany is currently not registered on the Peppol network.

What is the enterprise number of Société médicale Loze-Thilmany?

The enterprise number of Société médicale Loze-Thilmany is BE0783223233.

When was Société médicale Loze-Thilmany founded?

Société médicale Loze-Thilmany was founded on 9 March 2022.

Who are the directors of Société médicale Loze-Thilmany?

According to the 2025 annual accounts, the directors of Société médicale Loze-Thilmany are: Vincent LOZE, Sarah THILMANY.

Is Société médicale Loze-Thilmany a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 March 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Société médicale Loze-Thilmany make in 2025?

Société médicale Loze-Thilmany posted a profit after taxes of € 121,430 in financial year 2025.

What is the revenue of Société médicale Loze-Thilmany?

As a small company, Société médicale Loze-Thilmany is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 247,961.

Société médicale Loze-Thilmany (Private Limited) - Gesves

Dossier Société médicale Loze-Thilmany, printed on 31 October 2026 from databakkes.be/en/0783223233/societe-medicale-loze-thilmany. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Société médicale Loze-Thilmany from Gesves, company number BE0783223233, closed financial year 2025 with a result of € 121,430 after tax. For that financial year Société médicale Loze-Thilmany recorded a gross margin of € 247,961 and equity of € 55,445. Compared with financial year 2024, the result moved from € 106,590 to € 121,430. Profitable, and profit is growing. The buffer shrank hard: equity is 83 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Shrank hard

€ 55,445

▼ 83% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 121,430

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 76,626

▼ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 385,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 46,764

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 337,697

▼ 14% vs 2024

€ 59,100 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 201

▼ 92% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,601

▼ 13% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 184,584 Gross margin 2022: € 184,584 First fiscal year in the series	€ 164,300 Gross margin 2023: € 164,300 ▼ 11% vs 2022 (€ 184,584) Unfavourable step	€ 215,808 Gross margin 2024: € 215,808 ▲ 31% vs 2023 (€ 164,300) Favourable step	€ 247,961 Gross margin 2025: € 247,961 ▲ 15% vs 2024 (€ 215,808) Favourable step	▲ 15%
Profit after taxes	€ 118,988 Profit after taxes 2022: € 118,988 First fiscal year in the series	€ 88,438 Profit after taxes 2023: € 88,438 ▼ 26% vs 2022 (€ 118,988) Unfavourable step	€ 106,590 Profit after taxes 2024: € 106,590 ▲ 21% vs 2023 (€ 88,438) Favourable step	€ 121,430 Profit after taxes 2025: € 121,430 ▲ 14% vs 2024 (€ 106,590) Favourable step	▲ 14%
Equity	€ 123,988 Equity 2022: € 123,988 First fiscal year in the series	€ 212,426 Equity 2023: € 212,426 ▲ 71% vs 2022 (€ 123,988) Favourable step	€ 319,016 Equity 2024: € 319,016 ▲ 50% vs 2023 (€ 212,426) Favourable step	€ 55,445 Equity 2025: € 55,445 ▼ 83% vs 2024 (€ 319,016) Unfavourable step	▼ 83%
Total debts	€ 421,412 Total debts 2022: € 421,412 First fiscal year in the series	€ 282,426 Total debts 2023: € 282,426 ▼ 33% vs 2022 (€ 421,412) Favourable step	€ 472,873 Total debts 2024: € 472,873 ▲ 67% vs 2023 (€ 282,426) Unfavourable step	€ 654,369 Total debts 2025: € 654,369 ▲ 38% vs 2024 (€ 472,873) Unfavourable step	▲ 38%
Cash	€ 75,272 Cash 2022: € 75,272 First fiscal year in the series	€ 26,128 Cash 2023: € 26,128 ▼ 65% vs 2022 (€ 75,272) Unfavourable step	€ 96,493 Cash 2024: € 96,493 ▲ 269% vs 2023 (€ 26,128) Favourable step	€ 76,626 Cash 2025: € 76,626 ▼ 21% vs 2024 (€ 96,493) Unfavourable step	▼ 21%
Land & buildings	-	-	€ 299,794 Land & buildings 2024: € 299,794 First fiscal year in the series	€ 296,004 Land & buildings 2025: € 296,004 ▼ 1% vs 2024 (€ 299,794) Unchanged	▼ 1%
Retained profit	€ 118,988 Retained profit 2022: € 118,988 First fiscal year in the series	€ 207,426 Retained profit 2023: € 207,426 ▲ 74% vs 2022 (€ 118,988) Favourable step	€ 314,016 Retained profit 2024: € 314,016 ▲ 51% vs 2023 (€ 207,426) Favourable step	€ 50,445 Retained profit 2025: € 50,445 ▼ 84% vs 2024 (€ 314,016) Unfavourable step	▼ 84%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 385,000 Dividend 2025: € 385,000 Unchanged (€ 0) Unchanged
Bank debt	€ 32,532 Bank debt 2022: € 32,532 First fiscal year in the series	€ 72,367 Bank debt 2023: € 72,367 ▲ 122% vs 2022 (€ 32,532) Unfavourable step	€ 392,816 Bank debt 2024: € 392,816 ▲ € 320,449 vs 2023 (€ 72,367) Unfavourable step	€ 337,697 Bank debt 2025: € 337,697 ▼ 14% vs 2024 (€ 392,816) Favourable step	▼ 14%
Balance sheet total	€ 545,400 Balance sheet total 2022: € 545,400 First fiscal year in the series	€ 494,852 Balance sheet total 2023: € 494,852 ▼ 9% vs 2022 (€ 545,400) Unchanged	€ 791,888 Balance sheet total 2024: € 791,888 ▲ 60% vs 2023 (€ 494,852) Unchanged	€ 709,815 Balance sheet total 2025: € 709,815 ▼ 10% vs 2024 (€ 791,888) Unchanged	▼ 10%

Key figures of Société médicale Loze-Thilmany, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Société médicale Loze-Thilmany?

What happened at Société médicale Loze-Thilmany in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 121,430 (▲ 14% vs 2024). filed late Source: NBB ↗
Mar 9, 2022 New establishment in Gesves. KBO
Mar 9, 2022 Start of the company according to the CBE. KBO
2022 Vincent LOZE became a director. NBB
2022 Sarah THILMANY became a director. NBB

In short

From € 118,988 profit in 2022 to € 121,430 profit in 2025.

Paid € 120,818 in corporate taxes since 2022.

Best year ever: 2025, with € 121,430 profit.

Paid out € 385,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Vincent LOZE Sarah THILMANY

Société médicale Loze-Thilmany

Behind Société médicale Loze-Thilmany are Vincent LOZE and Sarah THILMANY.

Directors

According to the 2025 annual accounts

Vincent LOZE

Director

since 2022

Sarah THILMANY

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Labas 24

5340 Gesves

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0783.223.233
VAT number: BE 0783.223.233
Registered office: Rue de Labas 24, 5340 Gesves
Names & denominations: Société médicale Loze-Thilmany
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 March 2022
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗